NCT01583218 2023-08-07
APEX
Alexion Pharmaceuticals, Inc.
Phase 3 Completed
Clinical Trials
10 trialsNCT04462003 2020-07-08
DVT
Beni-Suef University
Phase 3 Unknown
NCT01058759 2018-08-22
Taxotere-Enoxaparin-(ENOXA)-Study
Hannover Medical School
Phase 3 Terminated
NCT00717938 2017-08-25
RASTEN
Lund University Hospital
Phase 3 Completed
NCT01356329 2016-05-13
Lovenox
National Guard Health Affairs
Phase 3 Suspended
NCT00718354 2015-05-13
GASTRANOX
Thrombosis Research Institute
Phase 3 Completed
NCT01164046 2014-12-03
Longheva
University Medical Center Groningen
Phase 3 Terminated
NCT00771563 2013-06-28
SYRINGES
University Hospital, Antwerp
Phase 3 Completed
NCT00723216 2010-04-05
Japanese Efficacy and Safety Study of Enoxaparin in Patients With Curative Abdominal Cancer Surgery
Sanofi
Phase 3 Completed
NCT00375076 2009-09-18
Comparison of Two Different Dosages of Low-molecular Weight Heparin in Cancer Patients
Medical University of Vienna
Phase 3 Completed